United States Fibromyalgia Treatment Market Expansion Fueled by Growing Awareness & Pipeline Drug Advancements | Key Players: Eli Lilly and Company., Pfizer Inc., AbbVie., Axsome Therapeutics, Inc., Scilex Holding, GSK plc, Bayer AG, Teva Pharmaceuticals

The global fibromyalgia treatment market reached US$ 2.83 billion in 2024 and is expected to reach US$ 3.88 billion by 2033, growing at a CAGR of 4.2 % during the forecast period 2025-2033.

The most recent report published by DataM Intelligence indicates that the "Fibromyalgia Treatment Market" is likely to accelerate significantly in the next few years. The Fibromyalgia Treatment Market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The Fibromyalgia Treatment Market study includes information on market factors such as the market dynamics, drivers, restraints, challenges, threats, potential growth opportunities, market trends, development patterns, financial information, latest technologies, innovations, leading competitors, and regional analysis of the market.

Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and sleep disturbances. The treatment market includes pharmacological therapies, lifestyle interventions, and alternative approaches like neuromodulation. In the U.S., recent news highlights increased insurance coverage for multidisciplinary care and ongoing trials for novel non-opioid drugs, indicating a stronger shift toward holistic and innovative pain management strategies.

Download Latest Sample of This Strategic Report (Use Corporate Email Id For Early Access) @ https://www.datamintelligence.com/download-sample/fibromyalgia-treatment-market?ophp

The list of Key Players Profiled in the study includes:- Eli Lilly and Company., Pfizer Inc., AbbVie., Axsome Therapeutics, Inc., Scilex Holding, GSK plc, Bayer AG, Teva Pharmaceuticals USA, Inc., Johnson & Johnson, and Tonix Pharmaceuticals Holding Corp.

United States: Recent Fibromyalgia Treatment Developments

📌 In August 2025, the U.S. Food and Drug Administration (FDA) approved Tonmya (cyclobenzaprine HCl sublingual tablets) for the management of fibromyalgia-related pain in adults. It is non-opioid, taken at bedtime, and the first FDA-approved therapy in over 15 years that specifically targets non-restorative sleep and reduces pain.

📌 In April 2025, Tonix Pharmaceuticals' investigational therapy TNX-102 SL (same as Tonmya) was in its final regulatory review phase with strong Phase 3 data showing pain reduction vs placebo at 14 weeks among nearly 1,000 patients. This marks a landmark in the fibromyalgia drug pipeline.

📌 In 2025, market analysis shows rising interest in biologics and digital health tools for fibromyalgia: greater investment in therapies targeting neuroinflammation and central nervous system pathways, and increasing adoption of symptom-tracking apps and telemedicine especially in emerging markets.

Japan: Recent Fibromyalgia Developments

📌 In March 2025, a Phase II clinical study of ONO-1110 in fibromyalgia patients began in Japan (160 participants), investigating its efficacy versus placebo.

📌 In 2025, a UMIN / ICDS registry trial was registered aiming to evaluate the clinical features of fibromyalgia in ~400 Japanese patients, to refine diagnosis and management strategies.

📌 In 2025, Japanese treatment reviews note that pregabalin (approved 2012) and duloxetine (approved 2015) remain primary pharmacologic options, with usage guided by clinical experience and patient characteristics

Market Dynamics:

✅Driver: Rising awareness and prevalence of chronic pain conditions increase demand for effective therapies.
✅Restraints: Lack of definitive diagnostic tools leads to underdiagnosis and undertreatment.
✅Opportunities: Ongoing R&D in novel therapeutics and non-pharmacological treatments create growth potential.
✅Challenges: Diverse symptom presentation and patient variability make treatment standardization difficult.

Segmentation Analysis of the Market:

Global Fibromyalgia Treatment Market forecast report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market. Fibromyalgia Treatment Market,
By Treatment Type (Acetaminophen, Antidepressants, Anti-Seizure Drugs, Therapies)
By Route of Administration (Oral, Parenteral)
By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Research Methodology:

- Primary Research: This method involves collecting new and original data for a specific purpose. Primary research is often conducted through surveys, interviews, focus groups, and observation. It enables researchers to obtain first-hand information directly from the target audience, which is especially useful when researching a new or emerging market.

- Secondary Research: This method involves analyzing and synthesizing existing data from various sources such as industry reports, government publications, academic research, and online databases. Secondary research can provide researchers with valuable insights into industry trends, consumer behavior, and Fibromyalgia Treatment market size and growth, without the need for extensive data collection.

Most research studies use a combination of both primary and secondary research methods to ensure comprehensive and accurate data analysis. The specific methodology used in a Fibromyalgia Treatment market research study will depend on various factors such as the research objectives, the target audience, and the available resources.

Request Customized Market Entry Assessment for North America, EU, APAC: https://www.datamintelligence.com/customize/fibromyalgia-treatment-market?ophp

Regional Outlook:

The following section of the report offers valuable insights into different regions and the key players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)

South America (Brazil, Argentina, Rest of SA)

Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

The analysis objectives of the report are:

- To determine the size of the Global Fibromyalgia Treatment Market by identifying its sub-segments.

- To research the key players and analyze their growth strategies.

- To assess the size and value of the Global Fibromyalgia Treatment Market based on key regions.

- To analyze the Global Fibromyalgia Treatment Market in terms of growth trends, potential, and participation in the overall sector.

- To investigate the Global Fibromyalgia Treatment Market size (volume and value) from the company, key regions/countries, goods and applications, and background data.

- Primary Global Fibromyalgia Treatment Market manufacturers to specify, clarify, and analyze the product sales volume, value, and market share, market rivalry landscape, SWOT analysis, and future development plans.

- To investigate market competitive developments such as market expansions, agreements, new product launches, and acquisitions.

Reasons to buy:

- Fibromyalgia Treatment Market Report segments the market based on economic and non-economic aspects and offers a qualitative and quantitative analysis of the market.

- Market value information is provided for each segment and sub-segment in the Fibromyalgia Treatment Market study.

- The region and market segment identified in this study are those predicted to expand the fastest and account for the majority of market shar

- The Fibromyalgia Treatment Market Analysis by Geography emphasizes the product or service's consumption in the area and identifies the market-affecting variables for each region.

- The major players' market rankings, as well as the recent partnerships, service/product launches, business expansions, and acquisitions of the companies profiled, are all included in the competitive landscape.

- Extensive company profiles for the top market players, including business overview, company insights, product benchmarking, and SWOT analysis.

- The industry's present and upcoming market outlook in consideration of recent changes, including growth possibilities and drivers as well as obstacles and restrictions in both developing and emerging regions.

- The Fibromyalgia Treatment Market offers comprehensive market analysis from a variety of angles using Porter's five forces analysis, as well as market insight using the Value Chain.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=fibromyalgia-treatment-market

The report answers a number of crucial questions, including:

- Which companies dominate the global Fibromyalgia Treatment market?

- What current trends will influence the market over the next few years?

- What are the market's opportunities, obstacles, and driving forces?

- What predictions for the future can help with strategic decision-making?

- What advantages does market research offer businesses?

Get Corporate Access to Live Fibromyalgia Treatment Industry Intelligence Database: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.